Advertisement
Interviews
View More
Trastuzumab and HER2-Targeted Therapy: Breaking Down the Basics

Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody drug conjugate trastuzumab deruxtecan.

‘Pharmacists Are the Care Coordinator’ in Type 1 Diabetes, Expert Says

Pharmacists help connect patients with the correct resources and help remove barriers so patients can receive continuous care.

Pharmacists Play Crucial Role in Screening and Educating Patients With Type 1 Diabetes

Pharmacists can educate patients and health care professionals in addition to coordinating lab orders, interpreting results, and guiding patients through the next steps.

Debunking Misconceptions and Understanding the Stages of Type 1 Diabetes

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, explains the different stages of type 1 diabetes, teplizumab’s use, and emphasizes the pharmacist’s role in care.

Expert Q&A: Empowering Independent Pharmacies Through the One Voice Initiative

Brad Cochran of Cardinal Health explains the One Voice Initiative, which aims to bolster independent pharmacies.

Video: Pharmacists Take Center Stage in Delivering Linvoseltamab, Advancing Myeloma Care

Sundar Jagannath, MBBS, highlights pharmacists’ expanding role in managing linvoseltamab’s immunologic profile, supporting adverse event response, and advancing multiple myeloma care.

Expert: Linvoseltamab’s Simplified Dosing Expands Access, Enhances Tolerability in Multiple Myeloma

Sundar Jagannath, MD, MBBS, discusses how linvoseltamab’s streamlined step-up dosing and REMS program support broader use in community settings and improved tolerability for older patients.

Integrated Care Pathways and Future Directions in COPD Management at UPMC

UPMC Health Plan enhances COPD care through personalized treatment, telemedicine, and comprehensive support, ensuring optimal patient outcomes and adherence.

Expert: FDA-Approved Linvoseltamab Delivers Deep Responses, Offering New Hope for Older Patients With MM

Sundar Jagannath, MD, MBBS, explains how linvoseltamab showed strong efficacy and tolerability in the LINKER-MM1 trial, making it an appealing option for older patients with relapsed or refractory multiple myeloma (MM).

Advertisement
Advertisement

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy